FDA Inspection 1168619 — Madhavi Ampajwala, M.D.
The FDA completed an inspection of Madhavi Ampajwala, M.D. on Apr 28, 2022 in Frisco, TX. The inspection was classified NAI (No Action Indicated — no objectionable conditions or practices were found during the inspection). Product area: Biologics.
Inspection Details
- Classification
- No Action Indicated (NAI)
- End Date
- Apr 28, 2022
- Fiscal Year
- 2022
- Product Type
- Biologics
- Project Area
- Vaccines and Allergenic Products
- Location
- Frisco, TX (United States)